A detailed history of Citigroup Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Citigroup Inc holds 34,445 shares of ATRC stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,445
Previous 32,116 7.25%
Holding current value
$1.06 Million
Previous $731,000 32.01%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$20.34 - $29.5 $47,371 - $68,705
2,329 Added 7.25%
34,445 $965,000
Q2 2024

Aug 12, 2024

BUY
$19.86 - $29.09 $370,011 - $541,975
18,631 Added 138.16%
32,116 $731,000
Q1 2024

May 10, 2024

BUY
$28.21 - $37.78 $125,562 - $168,158
4,451 Added 49.27%
13,485 $410,000
Q4 2023

Feb 09, 2024

BUY
$32.99 - $43.25 $209,123 - $274,161
6,339 Added 235.21%
9,034 $322,000
Q3 2023

Nov 09, 2023

SELL
$41.12 - $57.73 $773,878 - $1.09 Million
-18,820 Reduced 87.47%
2,695 $118,000
Q2 2023

Aug 10, 2023

BUY
$40.44 - $49.6 $676,682 - $829,956
16,733 Added 349.92%
21,515 $1.06 Million
Q1 2023

May 11, 2023

BUY
$35.87 - $47.22 $45,985 - $60,536
1,282 Added 36.63%
4,782 $198,000
Q4 2022

Feb 09, 2023

SELL
$33.48 - $47.45 $42,151 - $59,739
-1,259 Reduced 26.46%
3,500 $155,000
Q3 2022

Nov 10, 2022

SELL
$38.25 - $52.62 $94,286 - $129,708
-2,465 Reduced 34.12%
4,759 $186,000
Q2 2022

Aug 10, 2022

BUY
$35.1 - $66.01 $53,352 - $100,335
1,520 Added 26.65%
7,224 $295,000
Q1 2022

May 12, 2022

SELL
$57.43 - $71.39 $584,350 - $726,393
-10,175 Reduced 64.08%
5,704 $374,000
Q4 2021

Feb 10, 2022

BUY
$63.4 - $87.14 $433,529 - $595,863
6,838 Added 75.63%
15,879 $1.1 Million
Q3 2021

Nov 10, 2021

BUY
$69.28 - $84.46 $626,360 - $763,602
9,041 New
9,041 $629,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.